Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06872567 · ClinicalTrials.gov registry record · NA
Randomized Controlled Study Evaluating Genicular Artery Embolization Against Intra-Articular Corticosteroid Knee Injection for Osteoarthritic Knee Pain
A NA study of Knee Osteoarthritis (Knee OA), sponsored by North American Science Associates.
- Recruiting
- Registry status
- NA
- Development phase
- 126
- Enrollment target
- 1
- Study location
NCT06872567: Recruiting NA study of Knee Osteoarthritis (Knee OA), sponsored by North American Science Associates.
NCT06872567 is a NA study of Knee Osteoarthritis (Knee OA) that is actively recruiting participants, run by North American Science Associates. The registered enrollment target is 126 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06872567, a NA study of Knee Osteoarthritis (Knee OA), is actively recruiting participants, sponsored by North American Science Associates.
- RECRUITING
- Registry status
- NA
- Development phase
- 126 participants
- Enrollment target
- 1
- Study location
Study Summary
Multi-center, prospective, randomized trial of GAE using Nexsphere-F against steroid injection
Primary Outcome
Changes in total Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) score. Scale ranges from 0 to 96 with higher scores equating to greater pain, stiffness and difficulty with activities of daily living.
Conditions Studied
Interventions
- DEVICE genicular artery embolization
- DRUG Corticosteroid Injection
Study Locations (1)
Virginia
- University of Virginia - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2025-10-01 |
| Est. Completion | 2026-12 |
| Phase | NA |
What NCT06872567 shows while recruiting
NCT06872567 is an interventional study that assigns participants to a tested intervention. The registered 126 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Knee Osteoarthritis (Knee OA) appearing as the primary indexed condition, and to 2 interventions - of which genicular artery embolization is the first listed.
NCT06872567 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT06872567 about?
NCT06872567 is a clinical study titled "Randomized Controlled Study Evaluating Genicular Artery Embolization Against Intra-Articular Corticosteroid Knee Injection for Osteoarthritic Knee Pain". Multi-center, prospective, randomized trial of GAE using Nexsphere-F against steroid injection
What is the current status of trial NCT06872567?
This trial is currently recruiting. It is a NA study. The enrollment target is 126 participants. The study started on 2025-10-01. Estimated completion is 2026-12.
What conditions does trial NCT06872567 study?
This clinical trial studies the following conditions: Knee Osteoarthritis (Knee OA).
What interventions are being tested in trial NCT06872567?
The interventions under investigation include: genicular artery embolization (DEVICE), Corticosteroid Injection (DRUG).
Who is sponsoring clinical trial NCT06872567?
This trial is sponsored by North American Science Associates, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06872567 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Knee Osteoarthritis (Knee OA)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06872567's enrollment target sits among peer trials
126 749th of 2000 higher than 1,249 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01873131 · 126 participants · NA
A Clinical Trial of Pulsed-dye Laser Versus Timolol Topical Solution Versus Observation on the Growth of Hemangioma in Newborn
- NCT02621645 · 126 participants · Phase 4
TRAP Intervention STudy: Early Versus Late Intervention for Twin Reversed Arterial Perfusion Sequence
- NCT03838107 · 126 participants
Markers of Trajectory in Pediatric CRPS
- NCT03906422 · 126 participants · NA
Comparison of Patient-reported Pain After Initial Archwire Placement
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI